Smiths Detection today announces its Diagnostics business has signed a collaboration and licence agreement with Novartis Diagnostics under which Novartis is granted exclusive rights to market Smiths Detection’s Bio-Seeq instrument and the associated LATE PCR DNA analysis technology in the area of infectious disease diagnostics. Under the agreement, Smiths Detection will leverage its expertise in […]
Top Contract Research Organization Is Retained to Expedite Submission and Approval of the Company’s Pre-Symptomatic Ovarian Cancer Screening Test SUNNYVALE, CA–Arrayit Corporation (OTC.BB:ARYC – News), a leader in life sciences, healthcare and molecular diagnostics, announced today that the company has appointed DOCRO, Inc. of Seymour, Connecticut, to assist in obtaining FDA approval for OvaDx. DOCRO […]
CINCINNATI–Meridian Bioscience, Inc. announced today that it has submitted a 510(k) application to the United States Food and Drug Administration for marketing clearance of its new, simple molecular diagnostic test, illumigene™ C. difficile. illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory. […]
Launch over 30 New Kits for Nucleic Acid-Based Diagnostics THOROLD, ON — Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 30 new kits for nucleic-acid based diagnostics. Norgen makes best-in-class kits for nucleic acid […]
The Promega Maxwell® 16 IVD System is CE marked in accordance with the requirements of Directive 98/79/EC on in vitro diagnostic medical devices. The CE mark applies to the instrument, the Maxwell® 16 Blood DNA Purification System and the Maxwell® 16 Viral Total Nucleic Acid Purification System. The bench top automation system is fully compliant […]
Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation SAN DIEGO — Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation. A global leader […]
Enzo’s Third Molecular Diagnostics Agreement Provides Access to Multiplex Sequencing Technology NEW YORK–Enzo Biochem, Inc. (NYSE:ENZ – News) today announced that it has entered into an agreement with MultiGEN Diagnostics Inc., of San Diego, California, for exclusive rights to market MultiGEN’s unique diagnostic tests based on multiplex DNA sequencing, in the state of New York. […]
Powerful New Platform for New Molecular Diagnostic Tests ROCKVILLE, MD and SEOUL, KOREA — Seegene, Inc., a leader in multi-pathogen diagnostic testing, today unveiled a break-through technology called READ (Seegene Real Amplicon Detection) that marks a significant departure with current polymerase chain reaction (PCR) techniques that will enable an entirely new class of powerful molecular […]
Ships First International SmartChip System Following CE Certification – Company’s commercialization strategy to generate revenue through early access program and service prior to general availability FREMONT, Calif. — WaferGen Biosystems, Inc. (OTC Bulletin Board:WGBS.ob – News), a leading developer of state-of-the-art genetic analysis systems, today announced eight new early-access customers that include major universities and […]
NEW YORK–Enzo Biochem Inc. (NYSE:ENZ) announced today that Robert Boorstein, MD, PhD, an Associate Professor of Pathology at the NYU School of Medicine, has been appointed Medical Director of Enzo Clinical Labs, a full service clinical reference laboratory serving the metropolitan New York City medical community. “Dr. Boorstein brings with him over 25 years of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
